1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis

Immune Checkpoint Therapeutics - Hot Targets & Pipeline Analysis

  • April 2016
  • -
  • IQ4I Research & Consultancy Pvt. Ltd
  • -
  • 161 pages

“IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS” gives comprehensive insights on the various Immune Checkpoint modulators being developed for the treatment of various diseases. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins, Bi-specific Ab’s, Antibody drug conjugates, Cell therapy, Peptides, Oncolytic viruses and Vaccines.

The report also covers hot targets in research for Checkpoint modulators.
This report enables Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Medical technology companies, Service providers and other associated stake holders to identify and analyze the available licensing/collaborative commercial opportunities in the Immune Checkpoints Drug market. The report also provides strategic insights on medicines that are likely to have an impact on future Immune Checkpoint treatment space.

The report in addition to the monotherapy covers the pipeline for combination therapies associated only with checkpoint agents.
In order to effectively deal various diseases, the immune system needs to be able to generate an appropriate counter response. However, as a part of the natural fail–safe mechanism, to limit overactive immune responses that could lead to an auto-immune disease, there are a number of markers (“immune checkpoint receptors”) found on both tumor cells and antigen presenting cells (dendritic cells, macrophages etc.) that can down-regulate or suppress T cells once the corresponding ligand is bound.

Currently, Researchers are challenged to identify various avenues to prevent T cells from binding these tolerance-inducing ligands either through antibodies or recombinant forms of ligand or receptors. So, these T cells remain active and ready to tackle various diseases. Owing to its high response rate and prolonged overall patient survival the checkpoint therapeutics are gaining in popularity and have shown some impressive results in the areas of Oncology, Inflammation, Respiratory, Autoimmune and Infectious disease.

Table Of Contents

Immune Checkpoint Therapeutics - Hot Targets and Pipeline Analysis
REPORT DESCRIPTION INTRODUCTION
-Emerging role of immunotherapy
-Immune checkpoints
HOT TARGETS
-Immune checkpoints-Types
-Stimulatory checkpoint pathways
-Inhibitory checkpoint pathways
-Targets - Immune checkpoints -Other immune checkpoint targets
-Top companies based on revenue
-Top companies based on Pipeline
MARKET SIZING and DEALS ANALYSIS
-Market dynamics
-Market sizing
-Immune checkpoint Deals
PIPELINE ANALYSIS
-Development stage
-Leading players
-Target analysis
-Modalities
-Therapeutic Segmentation
-Oncology immune checkpoint pipeline by indication
SMALL MOLECULES
-Pipeline
-Competitive landscape MONOCLONAL ANTIBODIES
-Pipeline
-Competitive landscape RECOMBINANT FUSION PROTEINS
-Pipeline
-Competitive landscape BISPECIFIC ANTIBODIES
-Pipeline
-Competitive landscape ANTIBODY DRUG CONJUGATES (ADC's)
-Pipeline
-Competitive landscape
OTHERS
-Pipeline
-Competitive landscape
MAJOR PLAYERS
-Company Profiles
-Overview, Pipeline and Deals

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

OpportunityAnalyzer: Hyperparathyroidism - Opportunity Analysis and Forecasts to 2025 Summary Hyperparathyroidism (HPT) is a common endocrinal disorder characterized by excessive plasma levels of parathyroid ...

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second ...

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Hepatitis C Virus (HCV) Therapeutics - Global Drug Forecast and Market Analysis to 2025 Summary Hepatitis C virus (HCV) is a small, enveloped RNA virus that causes acute and chronic infections ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market and Cardiovascular Disease Statistics in the US

  • March 2017
    30 pages
  • Therapy  

    Cardiovascular ...  

    Cholesterol  

  • United States  

View report >

Therapy Market in the UK

  • March 2017
    50 pages
  • Therapy  

    Opioid  

  • United Kingdom  

    Europe  

View report >

Targeted Therapy Market in the US

  • March 2017
    13 pages
  • Targeted Therap...  

  • United States  

View report >

Diabetes Statistics

3 days ago

Related Market Segments :

Therapy
Monoclonal Antibody

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.